<DOC>
	<DOCNO>NCT00097734</DOCNO>
	<brief_summary>The purpose study compare efficacy ( assess clinical success treatment ) intravenous antibiotic therapy ertapenem patient acute attack sigmoid diverticulitis 4 vs. 7 day .</brief_summary>
	<brief_title>Study Evaluate Duration Treatment With Ertapenem Acute Attacks Sigmoid Diverticulitis</brief_title>
	<detailed_description />
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Diverticulitis , Colonic</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>At least three follow sign symptom acute attack sigmoid diverticulitis must present : *Fever ( body temperature &gt; 38°C , sublingual ) , *Abdominal tenderness , *Leukocytosis ( leukocytes &gt; 10,000/µl ) leave shift differential blood count ( &gt; 1 % band form ) , *Elevated CRP ( &gt; 20 mg/l ) Evidence sigmoid diverticulitis contrast enema CT evidence wall thicken sigmoid intestine Decision favor conservative therapy basis case history diagnosis Contraindication use study medication betalactam antibiotic , e.g . patient advance renal impairment patient require hemodialysis Antibiotic therapy two week prior start study Patients advance incurable disease Patients hematologic/oncologic disease ( leukemia , lymphoma ) Patients immunosuppressants Complications sigmoid diverticulitis lead immediate indication surgery Patients hypersensitivity betalactam antibiotic Female patient pregnant nursing could become pregnant study Participation another clinical study use another study drug within four week prior enrollment study use another drug study Each patient enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>diverticulitis</keyword>
	<keyword>Invanz</keyword>
	<keyword>Ertapenem</keyword>
	<keyword>acute attack</keyword>
	<keyword>sigmoid diverticulitis</keyword>
	<keyword>Acute attack sigmoid diverticulitis</keyword>
</DOC>